SCHEMBL10660016

SCHEMBL10660016

CC(C)COn1cc(F)c(=O)[nH]c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 6/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.46
▸ KDM4E B2RXH2 1/20 0.42
▸ CYP1A2 P05177 1/20 0.42
▸ GRIA1 P42261 1/20 0.42
▸ GRIA2 P42262 1/20 0.42
▸ GRIA3 P42263 1/20 0.42
▸ GRIA4 P48058 1/20 0.42
▸ GRIK5 Q16478 1/20 0.42
▸ KMT2A Q03164 1/20 0.38
▸ POLB P06746 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ MAPK3 P27361 1/20 0.35
▸ ASAH1 Q13510 1/20 0.35
▸ SQOR Q9Y6N5 1/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PMP22 Q01453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27574601 0.75 KDM4E (0.44) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL1226226 0.75 GRIA1 (0.60) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL11098374 0.73 LMNA (0.46) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL27831324 0.72 LMNA (0.45) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL9481857 0.72 SMN1; SMN2 (0.64) SMN1; SMN2KDM4ECYP1A2GRIA1GRIA2
SCHEMBL17897700 0.72 LMNA (0.54) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL27744847 0.70 LMNA (0.46) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL21465946 0.70 LMNA (0.56) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL27538958 0.70 LMNA (0.52) LMNASMN1; SMN2KDM4ECYP1A2GRIA1
SCHEMBL14478236 0.69 GRIA1 (0.66) LMNASMN1; SMN2KDM4ECYP1A2GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0265506-A1 A PRODRUG FORM OF 5-FLUOROURACIL AND A METHOD OF TREATMENT OF CANCER FARMACEUTISK LABORATORIUM FERRING A/S (DK) 1988-05-04 — — EP claimed
WO-1987006581-A1 A PRODRUG FORM OF 5-FLUOROURACIL AND A METHOD OF TREATMENT OF CANCER FARMACEUTISK LABORATORIUM FERRING A/S (DK) 1987-11-05 — — WO claimed
Send feedback